AAAAAA

   
Results: 1-10 |
Results: 10
HEREDITARY 1,25-DIHYDROXYVITAMIN D-RESISTANT RICKETS DUE TO AN OPAL MUTATION CAUSING PREMATURE TERMINATION OF THE VITAMIN-D-RECEPTOR
Authors: ZHU WJ MALLOY PJ DELVIN E CHABOT G FELDMAN D
Citation: Wj. Zhu et al., HEREDITARY 1,25-DIHYDROXYVITAMIN D-RESISTANT RICKETS DUE TO AN OPAL MUTATION CAUSING PREMATURE TERMINATION OF THE VITAMIN-D-RECEPTOR, Journal of bone and mineral research, 13(2), 1998, pp. 259-264
CYCLIC ADMINISTRATION OF PAMIDRONATE IN CHILDREN WITH SEVERE OSTEOGENESIS IMPERFECTA
Authors: GLORIEUX FH BISHOP NJ PLOTKIN H CHABOT G LANOUE G TRAVERS R
Citation: Fh. Glorieux et al., CYCLIC ADMINISTRATION OF PAMIDRONATE IN CHILDREN WITH SEVERE OSTEOGENESIS IMPERFECTA, The New England journal of medicine, 339(14), 1998, pp. 947-952
A NEW MUTATION IN GS-ALPHA PRESENTING AS SEVERE OSTEOGENESIS IMPERFECTA
Authors: BISHOP NJ GLORIEUX FH CHABOT G ROUGHLEY P REYES ML LANOUE G TRAVERS R
Citation: Nj. Bishop et al., A NEW MUTATION IN GS-ALPHA PRESENTING AS SEVERE OSTEOGENESIS IMPERFECTA, Journal of bone and mineral research, 12, 1997, pp. 652-652
TYPE-V OSTEOGENESIS IMPERFECTA
Authors: GLORIEUX FH BISHOP NJ TRAVERS R ROUGHLEY P CHABOT G LANOUE G FASSIER F GLORIEUX D HOPKINS E MARINI J
Citation: Fh. Glorieux et al., TYPE-V OSTEOGENESIS IMPERFECTA, Journal of bone and mineral research, 12, 1997, pp. 653-653
BENEFITS AND RISKS OF CONVENTIONAL THERAPY IN X-LINKED HYPOPHOSPHATEMIC RICKETS
Authors: GLORIEUX FH BISHOP NJ CHABOT G BERGERON E LANOUE G NASSER S
Citation: Fh. Glorieux et al., BENEFITS AND RISKS OF CONVENTIONAL THERAPY IN X-LINKED HYPOPHOSPHATEMIC RICKETS, Journal of bone and mineral research, 12, 1997, pp. 672-672
GENOMIC LOCALIZATION OF A NEW VARIANT OF OSTEOGENESIS IMPERFECTA TO CHROMOSOME 3P22-24.1
Authors: GLORIEUX FH LABUDA M BISHOP NJ LANOUE G CHABOT G TRAVERS R
Citation: Fh. Glorieux et al., GENOMIC LOCALIZATION OF A NEW VARIANT OF OSTEOGENESIS IMPERFECTA TO CHROMOSOME 3P22-24.1, Journal of bone and mineral research, 11, 1996, pp. 18-18
CLINICAL AND BONE DENSITOMETRIC IMPROVEMENT AFTER PAMIDRONATE INFUSION IN CHILDREN WITH SEVERE OSTEOGENESIS IMPERFECTA
Authors: BISHOP NJ LANOUE G CHABOT G TRAVERS R GLORIEUX FH
Citation: Nj. Bishop et al., CLINICAL AND BONE DENSITOMETRIC IMPROVEMENT AFTER PAMIDRONATE INFUSION IN CHILDREN WITH SEVERE OSTEOGENESIS IMPERFECTA, Journal of bone and mineral research, 11, 1996, pp. 645-645
CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER
Authors: ARMAND JP DUCREUX M MAHJOUBI M ABIGERGES D BUGAT R CHABOT G HERAIT P DEFORNI M ROUGIER P
Citation: Jp. Armand et al., CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER, European journal of cancer, 31A(7-8), 1995, pp. 1283-1287
PHASE I-II AND PHARMACOKINETIC STUDY OF A NEW FOTEMUSTINE SCHEDULE INADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: LECESNE A CHABOT G BERILLE J LUCAS C BAUD M GOUYETTE A MARTY M LECHEVALIER T
Citation: A. Lecesne et al., PHASE I-II AND PHARMACOKINETIC STUDY OF A NEW FOTEMUSTINE SCHEDULE INADVANCED NON-SMALL-CELL LUNG-CANCER, Lung cancer, 13(1), 1995, pp. 69-78
CARIOGENIC FEEDING-HABITS AND FLUORIDE SUPPLEMENTATION DURING INFANCYAND EARLY-CHILDHOOD
Authors: BERNARDBONNIN AC PELLETIER H TURGEON JP ALLARDDANSEREAU C PETIT N CHABOT G MASSON P
Citation: Ac. Bernardbonnin et al., CARIOGENIC FEEDING-HABITS AND FLUORIDE SUPPLEMENTATION DURING INFANCYAND EARLY-CHILDHOOD, Canadian journal of public health, 84(2), 1993, pp. 90-93
Risultati: 1-10 |